Diabetes insipidus

M Christ-Crain, DG Bichet, WK Fenske… - Nature reviews Disease …, 2019 - nature.com
Diabetes insipidus (DI) is a disorder characterized by excretion of large amounts of
hypotonic urine. Central DI results from a deficiency of the hormone arginine vasopressin …

Diagnosis and management of central diabetes insipidus in adults

M Tomkins, S Lawless, J Martin-Grace… - The Journal of …, 2022 - academic.oup.com
Central diabetes insipidus (CDI) is a clinical syndrome which results from loss or impaired
function of vasopressinergic neurons in the hypothalamus/posterior pituitary, resulting in …

[HTML][HTML] Arginine or hypertonic saline–stimulated copeptin to diagnose AVP deficiency

J Refardt, C Atila, I Chifu, E Ferrante… - … England Journal of …, 2023 - Mass Medical Soc
Background Distinguishing between arginine vasopressin (AVP) deficiency and primary
polydipsia is challenging. Hypertonic saline–stimulated copeptin has been used to diagnose …

Diagnosis and management of diabetes insipidus for the internist: an update

M Christ‐Crain, B Winzeler… - Journal of internal …, 2021 - Wiley Online Library
Diabetes insipidus is a disorder characterized by excretion of large amounts of hypotonic
urine. Four entities have to be differentiated: central diabetes insipidus resulting from a …

Arginine-stimulated copeptin measurements in the differential diagnosis of diabetes insipidus: a prospective diagnostic study

B Winzeler, N Cesana-Nigro, J Refardt, DR Vogt… - The Lancet, 2019 - thelancet.com
Background Differential diagnosis of diabetes insipidus is challenging. The most reliable
approach is hypertonic saline-stimulated copeptin measurements. However, this test is …

Diagnosis and management of central diabetes insipidus in adults

A Garrahy, C Moran, CJ Thompson - Clinical endocrinology, 2019 - Wiley Online Library
Central diabetes insipidus (CDI) is characterized by hypotonic polyuria due to impairment of
AVP secretion from the posterior pituitary. In clinical practice, it needs to be distinguished …

Vasopressin and Copeptin in health and disease

M Christ-Crain - Reviews in Endocrine and Metabolic Disorders, 2019 - Springer
Arginine Vasopressin (AVP) and copeptin derive from the same precursor molecule. Due to
the equimolar secretion, copeptin responds as rapidly as AVP to osmotic, hemodynamic and …

Endocrine side effects of immune checkpoint inhibitors

Z Cardona, JA Sosman, S Chandra… - Frontiers in …, 2023 - frontiersin.org
Immune checkpoint inhibitors (ICIs) have increasingly been the mainstay of treatment for
numerous malignancies. However, due to their association with autoimmunity, ICIs have …

Diabetes insipidus: an update

J Refardt, B Winzeler… - … and Metabolism Clinics, 2020 - endo.theclinics.com
Diabetes insipidus is one of the main causes of the polyuria polydipsia syndrome and is
characterized by a high hypotonic urinary output of more than 50 mL/kg body weight per 24 …

New insights on diagnosis and treatment of AVP deficiency

J Refardt, C Atila, M Christ-Crain - Reviews in Endocrine and Metabolic …, 2024 - Springer
Arginine vasopressin deficiency (AVP-D) is one of the main entities of the polyuria-
polydipsia syndrome. Its correct diagnosis and differentiation from the other two causes-AVP …